Please provide your email address to receive an email when new articles are posted on . During the past 18 months, two novel oral anticoagulants were approved by the FDA for the prevention of stroke ...

The American College of Cardiology 62nd Annual Scientific Session & Expo featured a daylong program on advances in pharmacology. One session in particular, "Pharmacologic Considerations with the New ...

April 18, 2012 (Chieti, Italy) — In a "position paper" on the new oral anticoagulants, a group of experts from the European Society of Cardiology Working Group on Thrombosis are enthusiastic about the ...

While randomized trials of 3 novel oral anticoagulants have shown that they are comparable or superior to warfarin for preventing stroke in patients with atrial fibrillation (A-fib), clinicians have ...

Drugmakers have turned new generation anticoagulants into blockbusters as treatments for strokes and heart attacks, but one area of care where they have made little progress is for treating atrial ...

CVD Screening May Benefit Men with ED Treatment visits for use of anticoagulants are on an upward trend and driven largely by the popularity of new direct oral anticoagulants, which tripled in use ...

Please provide your email address to receive an email when new articles are posted on . In the next few years, there will be a shift from warfarin to the new anticoagulants. In the countries where ...

ANN ARBOR, Mich. - More adults than ever are visiting their doctors' offices for a prescription to treat atrial fibrillation, according to a study led by the University of Michigan Frankel ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The AMPLIFY investigators randomized 5,395 patients with acute venous ...

Edoxaban, a direct oral factor Xa inhibitor under development by Daiichi Sankyo, is the latest in the series of new oral anticoagulants seeking to take over the troubled role of warfarin in clinical ...